Literature DB >> 17891392

Classic tumour imaging agents for glioma evaluation: 99mTc-tetrofosmin.

George A Alexiou, Spyridon Tsiouris, Athanasios P Kyritsis, Konstantinos S Polyzoidis, Andreas D Fotopoulos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17891392     DOI: 10.1007/s00259-007-0590-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  10 in total

Review 1.  Single-photon agents for tumor imaging: 201Tl, 99mTc-MIBI, and 99mTc-tetrofosmin.

Authors:  Mitsutaka Fukumoto
Journal:  Ann Nucl Med       Date:  2004-04       Impact factor: 2.668

2.  Tc-99m Tetrofosmin SPECT for the differentiation of a cerebellar hemorrhage mimicking a brain metastasis from a renal cell carcinoma.

Authors:  G A Alexiou; J A Bokharhii; A P Kyritsis; K S Polyzoidis; A D Fotopoulos
Journal:  J Neurooncol       Date:  2006-03-31       Impact factor: 4.130

3.  Evaluation of glioma proliferation by 99mTc-Tetrofosmin.

Authors:  George A Alexiou; Spyridon Tsiouris; Ann Goussia; Athanasios Papadopoulos; Athanasios P Kyritsis; Konstantinos S Polyzoidis; Andreas D Fotopoulos
Journal:  Neuro Oncol       Date:  2007-11-30       Impact factor: 12.300

4.  Thallium-201 SPECT imaging of brain tumors: methods and results.

Authors:  K T Kim; K L Black; D Marciano; J C Mazziotta; B H Guze; S Grafton; R A Hawkins; D P Becker
Journal:  J Nucl Med       Date:  1990-06       Impact factor: 10.057

5.  Brain tumor imaging with 99mTc-tetrofosmin: comparison with 201Tl, 99mTc-MIBI, and 18F-fluorodeoxyglucose.

Authors:  J Y Choi; S E Kim; H J Shin; B T Kim; J H Kim
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

6.  Differentiating histologic malignancy of primary brain tumors: pentavalent technetium-99m-DMSA.

Authors:  T Hirano; H Otake; T Shibasaki; M Tamura; K Endo
Journal:  J Nucl Med       Date:  1997-01       Impact factor: 10.057

7.  123I-2-iodo-tyrosine, a new tumour imaging agent: human biodistribution, dosimetry and initial clinical evaluation in glioma patients.

Authors:  Marleen Keyaerts; Tony Lahoutte; Bart Neyns; Vicky Caveliers; Chris Vanhove; Hendrik Everaert; Ken Kersemans; Philippe R Franken; John Mertens; Axel Bossuyt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-20       Impact factor: 9.236

8.  Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy.

Authors:  C Soler; P Beauchesne; K Maatougui; T Schmitt; F G Barral; D Michel; F Dubois; J Brunon
Journal:  Eur J Nucl Med       Date:  1998-12

9.  Pentavalent technetium-99m dimercaptosuccinic acid [99m Tc-(V)DMSA] brain scintitomography--a plausible non-invasive depicter of glioblastoma proliferation and therapy response.

Authors:  Spyridon Tsiouris; Ioannis Pirmettis; Theodoros Chatzipanagiotou; Nikolaos Ptohis; Vassilios Papantoniou
Journal:  J Neurooncol       Date:  2007-06-07       Impact factor: 4.130

10.  Evaluation of brain tumor recurrence by (99m)Tc-tetrofosmin SPECT: a prospective pilot study.

Authors:  George A Alexiou; Andreas D Fotopoulos; Athanasios Papadopoulos; Athanasios P Kyritsis; Konstantinos S Polyzoidis; Spyridon Tsiouris
Journal:  Ann Nucl Med       Date:  2007-07-25       Impact factor: 2.668

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.